These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 33005293)
1. Prognostic significance of Borrmann type combined with vessel invasion status in advanced gastric cancer. Zhai Z; Zhu ZY; Zhang Y; Yin X; Han BL; Gao JL; Lou SH; Fang TY; Wang YM; Li CF; Yu XF; Ma Y; Xue YW World J Gastrointest Oncol; 2020 Sep; 12(9):992-1004. PubMed ID: 33005293 [TBL] [Abstract][Full Text] [Related]
2. Retrospective evaluation of lymphatic and blood vessel invasion and Borrmann types in advanced proximal gastric cancer. Gao S; Cao GH; Ding P; Zhao YY; Deng P; Hou B; Li K; Liu XF World J Gastrointest Oncol; 2019 Aug; 11(8):642-651. PubMed ID: 31435465 [TBL] [Abstract][Full Text] [Related]
3. Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer. Du CY; Chen JG; Zhou Y; Zhao GF; Fu H; Zhou XK; Shi YQ World J Gastroenterol; 2012 Jul; 18(27):3610-6. PubMed ID: 22826628 [TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors of lymph node-negative metastasis gastric cancer]. Sun D; Xu H; Huang J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354 [TBL] [Abstract][Full Text] [Related]
5. [Rationality of N3 classification and its sub-classification in TNM classification system for advanced gastric cancer]. Cheng Y; Huang J; Zhu Z; Xu H Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):749-55. PubMed ID: 27452751 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Hyung WJ; Lee JH; Choi SH; Min JS; Noh SH Ann Surg Oncol; 2002 Jul; 9(6):562-7. PubMed ID: 12095972 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer. Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164 [TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features. Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and prognosis of Borrmann type IV gastric cancer. Zhu YL; Yang L; Sui ZQ; Liu L; Du JF J BUON; 2016; 21(6):1471-1475. PubMed ID: 28039710 [TBL] [Abstract][Full Text] [Related]
10. Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. del Casar JM; Corte MD; Alvarez A; García I; Bongera M; González LO; García-Muñiz JL; Allende MT; Astudillo A; Vizoso FJ J Cancer Res Clin Oncol; 2008 Feb; 134(2):153-61. PubMed ID: 17628829 [TBL] [Abstract][Full Text] [Related]
11. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer. Li C; Oh SJ; Kim S; Hyung WJ; Yan M; Zhu ZG; Noh SH Oncology; 2009; 77(3-4):197-204. PubMed ID: 19729977 [TBL] [Abstract][Full Text] [Related]
12. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach]. Dong R; Zhang Z; Zhou Y; Hua Y; Guo J Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918 [TBL] [Abstract][Full Text] [Related]
13. Borrmann type IV gastric cancer should be classified as pT4b disease. Huang JY; Wang ZN; Lu CY; Miao ZF; Zhu Z; Song YX; Xu HM; Xu YY J Surg Res; 2016 Jun; 203(2):258-67. PubMed ID: 27363630 [TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer]. Song S; Liu H; Xue Y Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses. Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608 [TBL] [Abstract][Full Text] [Related]
16. [Study on the clinicopathologic characteristics and prognostic difference of gastric stump cancer between non-anastomotic site and anastomotic site]. Chen L; Wei S; Ye Z; Wang Y; Zheng Q; Zhuo C; Xiao J; Zeng Y Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):67-72. PubMed ID: 28105623 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China. Song XH; Zhang WH; Kai-Liu ; Chen XL; Zhao LY; Chen XZ; Kun-Yang ; Zhou ZG; Hu JK World J Surg Oncol; 2020 Aug; 18(1):204. PubMed ID: 32792016 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma]. Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357 [TBL] [Abstract][Full Text] [Related]
19. Borrmann type IV: an independent prognostic factor for survival in gastric cancer. An JY; Kang TH; Choi MG; Noh JH; Sohn TS; Kim S J Gastrointest Surg; 2008 Aug; 12(8):1364-9. PubMed ID: 18516653 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological analysis of Borrmann type IV gastric cancer. Yook JH; Oh ST; Kim BS Cancer Res Treat; 2005 Apr; 37(2):87-91. PubMed ID: 19956485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]